Objective: This study aimed to systematically document the reported omega-3 levels in commercially available prenatal supplements in the United States and Canada, and compare these levels to recommended intakes in pregnancy.
Study Design: Commercial prenatal supplements were identified using the Dietary Supplement Label Database ( = 50) and the Licensed Natural Health Products Database ( = 18). Mean omega-3 levels and the proportion of products meeting recommendations for pregnant women were tabulated.